'Real Challenge' To Improve OTC Monograph Program Without User Fees – FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA looks at the potential benefits and detriments from establishing user fees for the monograph program, opening a docket for comments in addition to conducting the public meeting, as it also considers comments to a docket launched in February 2014 on overhauling the OTC monograph process.
You may also be interested in...
Clock Ticks On Adding OTC Monograph Reform To FDA User Fees Bill
With Congress leaving Washington for Independence Day week and much of August, few days remain to consider adding to each chamber's reauthorization legislation language from Sens. Isakson and Casey's discussion draft for US OTC monograph reform and a user fee program to support FDA's work.
Clock Ticks On Adding OTC Monograph Reform To FDA User Fees Bill
With Congress leaving Washington for Independence Day week and much of August, few days remain to consider adding to each chamber's reauthorization legislation language from Sens. Isakson and Casey's discussion draft for US OTC monograph reform and a user fee program to support FDA's work.
Clock Ticks On Adding OTC Monograph Reform To FDA User Fees Bill
With Congress leaving Washington for Independence Day week and much of August, few days remain to consider adding to each chamber's reauthorization legislation language from Sens. Isakson and Casey's discussion draft for US OTC monograph reform and a user fee program to support FDA's work.